Proceedings: Adrenocorticotrophin (ACTH) and beta-melanocyte-stimulating hormone peptides in tumours associated with the ectopic ACTH syndrome. 1973

G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees

UI MeSH Term Description Entries
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D006729 Hormones, Ectopic Hormones released from neoplasms or from other cells that are not the usual sources of hormones. Ectopic Hormone,Ectopic Hormones,Hormone, Ectopic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
November 1978, The Journal of endocrinology,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
November 1974, The Journal of endocrinology,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
March 1980, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
February 1977, The American journal of medicine,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
August 1974, Proceedings of the Royal Society of Medicine,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
February 1986, International journal of peptide and protein research,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
November 1965, The Journal of biological chemistry,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
May 1979, Biochemical and biophysical research communications,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
October 1960, Proceedings of the staff meetings. Mayo Clinic,
G Bloomfield, and J G Ratcliffe, and A P Scott, and P J Lowry, and L H Rees
January 1976, Ciba Foundation symposium,
Copied contents to your clipboard!